Characterization of Staphylococci with reduced susceptibilities to vancomycin and other glycopeptides

Journal of Clinical Microbiology

Volumn 36, Issue 4, 1998, Pages 1020-1027

  Tenover, Fred C ^a   Lancaster, Michael V ^a   Hill, Bertha C ^a   Steward, Christine D ^a   Stocker, Sheila A ^a   Hancock, Gary A ^a   O'Hara, Caroline M ^a   Clark, Nancye C ^a   Hiramatsu, Keiichi ^b  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL DNA; DALFOPRISTIN PLUS QUINUPRISTIN; EVERNIMICIN; LINEZOLID; ORITAVANCIN; TEICOPLANIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STRAIN DIFFERENCE;

EID: 0031943172     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.36.4.1020-1027.1998     Document Type: Article

References (38)

1. Aarestrup, F. M., P. Ahrens, M. Madsen, L. V. Pallesen, R. L. Poulsen, and H. Westh. 1996. Glycopeptide susceptibility among Danish Enterococcus faecium and Enterococcus faecalis isolates of animal and human origin and PCR identification of genes within the VanA cluster. Antimicrob. Agents Chemother. 40:1938-1940.
2. AB Biodisk America Inc. 1996. Etest package insert. AB Biodisk North America Inc., Piscataway, N.J.
3. Archer, G. L., P. Auger, G. V. Doern, M. J. Ferraro, P. C. Fuchs, J. H. Jorgensen, D. E. Low, P. R. Murray, L. B. Reller, C. W. Stratton, C. B. Wennersten, and R. C. Moellering, Jr. 1993. RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci. Diagn. Microbiol. Infect. Dis. 16:223-226.
4. Bannerman, T. L., G. A. Hancock, F. C. Tenover, and J. M. Miller. 1995. Pulsed-field gel electrophoresis as a replacement for bacteriophage typing of Staphylococcus aureus. J. Clin. Microbiol. 33:551-555.
5. Barna, J. C., and D. H. Williams. 1984. The structure and mode of action of glycopeptide antibiotics of the vancomycin group. Annu. Rev. Microbiol. 38:339-357.
6. Centers for Disease Control and Prevention. 1993. Nosocomial enterococci resistant to vancomycin - United States, 1989-1993. Morbid. Mortal. Weekly Rep. 42:597-599.
7. Centers for Disease Control and Prevention. 1995. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). Morbid. Mortal. Weekly Rep. Rec. Rep. 44(12):1-20.
8. Centers for Disease Control and Prevention. 1997. Reduced susceptibility of Staphylococcus aureus to vancomycin - Japan, 1996. Morbid. Mortal. Weekly Rep. 46:624-626.
9. Centers for Disease Control and Prevention. 1997. Staphylococcus aureus with reduced susceptibility to vancomycin - United States, 1997. Morbid. Mortal. Weekly Rep. 46:765-766.
10. Centers for Disease Control and Prevention. 1997. Interim guidelines for prevention and control of staphylococcal infection associated with reduced susceptibility to vancomycin. Morbid. Mortal. Weekly Rep. 46:626-628, 635-636.
11. Clark, N. C., R. C. Cooksey, B. C. Hill, J. M. Swenson, and F. C. Tenover. 1993. Characterization of glycopeptide-resistant enterococci from U.S. hospitals. Antimicrob. Agents Chemother. 37:2311-2317.
12. Clark, N. C., L. M. Teixeira, R. R. Facklam, and F. C. Tenover. 1997. Detection and differentiation of the vanC-1, vanC-2, and vanC-3 glycopeptide resistance genes in enterococci, abstr. E-125, p. 86. In Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
13. Daum, R. S., S. Gupta, R. Sabbagh, and W. M. Milewski. 1992. Characterization of Staphylococcus aureus isolates with decreased susceptibility to vancomycin and teicoplanin: isolation and purification of a constitutively produced protein associated with decreased susceptibility. J. Infect. Dis. 166:1066-1072.
14. Garrett D. O., E. Jochimsen, K. Murfitt, B. Hill, S. McAllister, P. Nelson, R. Spera, R. Sall, F. Tenover, and W. Jarvis. 1997. The impending apocalypse; the emergence of vancomycin resistance in Staphylococcus spp., abstr. S1. In Abstracts of the 7th Annual Meeting of the Society for Healthcare Epidemiology of America. Infect. Control Hosp. Epidemiol. 18(Suppl.): P32.
15. Gordts, B., H. Van Landuyt, M. Ieven, P. Vandamme, and H. Goossens. 1995. Vancomycin-resistant enterococci colonizing the intestinal tracts of colonized patients. J. Clin. Microbiol. 33:2842-2846.
16. Hiramatsu, K., N. Aritaka, H. Hanaki, S. Kawasaki, Y. Hosoda, S. Hori, Y. Fuckuchi, and I. Kobayashi. 1997. Vancomycin-resistant Staphylococcus aureus: dissemination of heterogeneously resistant strains in Japanese hospital. Lancet 350:1670-1673.
17. Hiramatsu, K., H. Hanaki, T. Ino, K. Yabuta, T. Oguri, and F. C. Tenover. 1997. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40:135-136.
18. Jones, R. N., H. S. Sader, M. E. Erwin, S. C. Anterson, and the Enterococcus Study Group. 1995. Emerging multiply resistant enterococci among clinical isolates. I. Prevalence data from a 97 medical center surveillance study in the United States. Diagn. Microbiol. Infect. Dis. 21:85-93.
19. Kloos, W. E., and T. L. Bannerman. 1995. Staphylococcus and Micrococcus, p. 282-298. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.
20. Leclerq, R., E. Derlot, J. Duval, and P. Courvalin. 1988. Plasmid-mediated vancomycin and teicoplanin resistance in Enterococcus faecium. N. Engl. J. Med. 319:157-161.
21. Mitsuyama, J., H. Yamada, J. Maehana, Y. Fukuda, S. Kurose, S. Minami, Y. Todo, Y. Watanabe, and H. Narita. 1997. Characteristics of quinolone-induced small colony variants in Staphylococcus aureus. J. Antimicrob. Chemother. 39:697-705.
22. Montecalvo, M. A., H. Horowicz, C. Gedris, C. Carbonaro, F. C. Tenover, A. Issah, P. Cook, and G. P. Wormser. 1994. Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob. Agents Chemother. 38:1363-1367.
23. Moreira, B., S. Boule-Vavra, L. Boudewijn, M. Dejonge, and R. S. Daum. 1997. Increased production of penicillin-binding protein 2, increased detection of other penicillin-binding proteins, and decreased coagulase activity associated with glycopeptide resistance in Staphylococcus aureus. Antimicrob. Agent Chemother. 41:1788-1793.
24. Morris, J. G., Jr., D. K. Shay, J. N. Hebden, R. J. McCarter, B. E. Perdue, W. Jarvis, J. A. Johnson, T. C. Dowling, L. B. Polish, and R. S. Schwalbe. 1995. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Ann. Intern. Med. 123:250-259.
25. Mulazimoglu, L., S. D. Drenning, and V. L. Yu. 1996. In vitro activities of two novel oxazolidinones (U100592 and U100766), a new fluoroquinolone (trovafloxacin), and dalfopristin-quinupristin against Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob. Agents Chemother. 40:2428-2430.
26. National Committee for Clinical Laboratory Standards. 1997. Performance standards for antimicrobial disk susceptibility tests, 6th ed., vol. 17, no. 1. Approved standard M2-A6. National Committee for Clinical Laboratory Standards, Wayne, Pa.
27. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed., vol. 17, no. 2. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
28. Noble, W. C., Z. Virani, and R. Cree. 1992. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol. Lett. 93:195-198.
29. O'Callaghan, C. H., A. Morris, S. M. Kirby, and A. H. Shingler. 1972. Novel method tor detection of β-lactamases by using a chromogenic cephalosporin substrate. Antimicrob. Agents Chemother. 1:283-288.
30. Reynolds, P. E. 1989. Structure, biochemistry, and mechanism of action of glycopeptide antibiotics. Eur. J. Clin. Microbiol. Infect. Dis. 8:943-950.
31. Satake, S. N., N. C. Clark, D. Rimland, F. S. Nolte, and F. C. Tenover. 1997. Detection of vancomycin-resistant enterococci in fecal samples by PCR. J. Clin. Microbiol. 35:2325-2330.
32. Schwalbe, R. S., A. C. McIntosh, S. Qaiyumi, J. A. Johnson, R. J. Johnson, K. M. Furness, W. J. Holloway, and L. Steele-Moore. 1996. In vitro activity of LY333328, an investigational glycopeptide antibiotic, against enterococci and staphylococci. Antimicrob. Agents Chemother. 40:2416-2419.
33. Sieradzki, K., and A. Tomasz. 1997. Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus. J. Bacteriol. 179:2557-2566.
34. Swenson, J. M., N. C. Clark, D. F. Sahm, M. J. Ferraro, G. Doern, J. Hindler, J. U. Jorgensen, M. A. Pfaller, L. B. Reller, M. P. Weinstein, R. J. Zabransky, and F. C. Tenover. 1995. Molecular characterization and multilaboratory evaluation of Enterococcus faecalis ATCC 51299 for quality control of screening tests for vancomycin and high-level aminoglycoside resistance in enterococci. J. Clin. Microbiol. 33:3019-3021.
35. Swenson, J. M., N. C. Clark, M. J. Ferraro, D. F. Sahm, G. Doern, M. A. Pfaller, L. B. Reller, M. P. Weinstein, R. J. Zabransky, and F. C. Tenover. 1994. Development of a standardized screening method for detection of vancomycin-resistant enterococci. J. Clin. Microbiol. 32:1700-1704.
36. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced hy pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2339.
37. Uttley, A. H., C. H. Collins, J. Naidoo, and R. C. George. 1988. Vancomycin-resistant enterococci. Lancet i:57-58.
38. Verbist, L. 1993. Relevance of antibiotic susceptibility testing for clinical practice. Eur. J. Clin. Microbiol. Infect. Dis. 12(Suppl. 1):2-5.